ICMR, Panacea Biotec begin Ph-3 trial of indigenous dengue vaccine The Tribune IndiaPhase three clinical trial of India’s own dengue vaccine, DengiAll, initiated The Times of IndiaPanacea Biotec shares up 5% as phase-3 trial of India’s first dengue vaccine ‘DengiAll’ begins UpstoxICMR, Panacea Biotec begin first-ever phase 3 clinical trial of made-in-India dengue vaccine The New Indian ExpressDengue vaccine: Phase-3 of trial begins in Rohtak The Indian Express ICMR, Panacea Biotec begin Ph-3 trial of indigenous dengue vaccine The Tribune IndiaPhase three clinical trial of India’s own dengue vaccine, DengiAll, initiated The Times of IndiaPanacea Biotec shares up 5% as phase-3 trial of India’s first dengue vaccine ‘DengiAll’ begins UpstoxICMR, Panacea Biotec begin first-ever phase 3 clinical trial of made-in-India dengue vaccine The New Indian ExpressDengue vaccine: Phase-3 of trial begins in Rohtak The Indian Express Top stories – Google News
Headlines
